Five-year outcomes of alcohol-dependent persons treated with motivational enhancement.
Five-year outcomes of alcohol-dependent persons treated with motivational enhancement.
复制标题
经过动机增强治疗的酒精依赖者的五年结果。
DOI：
10.15288/jsad.2008.69.589
复制
发表时间：
2008
影响因子：
3.4
通讯作者：
J. Sellman
中科院分区：
文献类型：
--
作者：
S. Adamson;J. Sellman
目的
本研究的目的是确定动机增强疗法（MET）先前在6个月时证实的上级治疗效果是否在治疗后5年随访时得以维持。
方法
轻度至中度酒精依赖的患者完成了一项试验，所有患者都接受了评估，参加了简短的反馈会议，并被随机分配到四个会议的MET，非指导性反射性倾听，或没有进一步的咨询。主要饮酒结果是明确的重度饮酒（UHD），定义为在6个月内6次或6次以上饮用10种或以上标准饮料。在6个月随访时，122例患者中有108例同意进一步随访。
结果
77例患者在完成治疗后成功随访了平均（SD）58（14）个月。尽管整个组的情况继续改善，UHD的发生率从6个月时的51%降低到5年时的25%，但治疗组在UHD饮酒或一系列较低的饮酒阈值方面没有差异。
结论
虽然3个治疗组的5年结局无明显差异，但这是比较条件下的患者赶上MET患者饮酒量增加的结果，而不是MET患者饮酒量恶化的结果。分配接受MET的个体比任何一种比较治疗条件更快地实现更大的减少。
OBJECTIVE
The purpose of this study was to determine whether the superior treatment effect of motivational enhancement therapy (MET) previously demonstrated at 6 months was sustained at a 5-year posttreatment follow-up.
METHOD
Patients with mild to moderate alcohol dependence had completed a trial in which all patients were assessed, attended a brief feedback session, and were randomized to four sessions of MET, nondirective reflective listening, or no further counseling. The primary drinking outcome was unequivocal heavy drinking (UHD), defined as drinking 10 or more standard drinks on six or more occasions over a 6-month period. At the 6-month follow-up, 108 of 122 patients agreed to a further follow-up interview.
RESULTS
Seventy-seven patients were successfully followed for a mean (SD) of 58 (14) months after the completion of treatment. Although the group as a whole had continued to improve, with rates of UHD reduced from 51 % at 6 months to 25% at 5 years, there was no difference by treatment group in drinking for UHD or a range of lower drinking thresholds.
CONCLUSIONS
Although 5-year outcomes were indistinguishable among the three treatment groups, this was the result of patients in the comparison conditions catching up to the drinking gains of MET patients rather than a deterioration in drinking for MET patients. Individuals allocated to receive MET achieved a greater reduction sooner than either of the comparison treatment conditions.